The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Kezar Life Sciences’ zetomipzomib, an ...

The Walk to End Lupus Now Delaware is part of the Lupus Foundation of America’s signature walk program. Hosted by the Pennsylvania Delaware Valley Region of the Lupus Foundation of America, this walk ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

New study finds that Black children and those identifying with more than one race have higher disease activity and are less likely to achieve low lupus disease activity state compared to White ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...